← FDA DRUG APPROVALS

FDA NDA · NDA012674

HEXADROL

Sponsor: ASPEN GLOBAL INC

APPLICATION
NDA012674
TYPE
NDA
ORIGINAL APPROVAL
1960-12-21
LATEST ACTION
2024-06-05
ROUTE
ORAL
DOSAGE FORM
ELIXIR
MARKETING STATUS
Discontinued

Products

HEXADROLDiscontinued
DEXAMETHASONE 0.5MG/5ML · ELIXIR · ORAL

Approval history

2024-06-05Labeling · Supplement 10 · standardLabelAP
1989-05-11Manufacturing (CMC) · Supplement 8 · standardAP
1987-06-02Manufacturing (CMC) · Supplement 9 · standardAP
1984-06-18Manufacturing (CMC) · Supplement 7 · standardAP
1960-12-21Type 5 - New Formulation or New Manufacturer · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →